Background: Understanding the evolution of entry phenotype of HIV-1 is essential for our understanding of HIV-1 pathogenesis, latency, and disease progression. The use of a more precise assay to define entry phenotype based on the ability of HIV-1 to use low levels of CD4 for efficient entry has clarified the relationship of viruses that have evolved to infect macrophages as distinct from R5 viruses that predominantly replicate in T cells. We have used this assay to identify infrequent examples of macrophage-tropic (M-tropic) viruses and partially M-tropic viruses (intermediate) in cerebral spinal fluid and genital tract. However the prevalence of M-tropic viruses in other compartments, such as the blood, remains unknown. We set out to determine if M-tropic viruses ever reach a point of systemic infection.
Methods: Viral RNA was isolated from blood plasma samples from viremic subjects infected with either subtype B or subtype C HIV-1, and with CD4+ T cell counts of <100 cell/mm3. Individual env gene were isolated, cloned and analyzed for receptor usage using Affinofile cells, in order to determine the viral entry phenotype. Susceptibility of pseudoviruses to soluble CD4 was also evaluated.
Results: 18 subtype B and 20 subtype C late-stage infected subjects were examined. As expected for late stage subjects, we identified X4 lineages in over 50% of the subjects. To date, no examples of efficient use of low CD4 for entry (M-tropic virus) have been found in the blood. However, we do occasionally see a level of infection on CD4-low cells that is marginally greater than that of the typical R5 T cell-tropic virus. This intermediate phenotype has also been seen in the CSF and genital tract. This new group of viruses showed increased sensitivity to soluble CD4 that is comparable to macrophage-tropic viruses.
Conclusions: Using the definition of M-tropic virus as the ability to utilize low levels of CD4, leads to the conclusion that these variants are rare and are potentially limited to specific compartments of the body. The appearance of intermediate phenotypes in the blood argues that there may be some evolution toward macrophage tropism taking place in compartments that shed virus into the blood late in disease. The high level of sensitivity to soluble CD4 among intermediate viruses suggests that the evolution to M-tropism is at least a two-step process where the viruses first become more sensitive to interaction with CD4 followed by more efficient fusion.